Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
MLTX —
MOONLAKE IMMUNOTHERAPEUTICS
CUSIP: 61559X104 · Held by 2 superinvestors · Combined value: $32,024,263
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $30,251,922 | 2,295,290 | ADD | +1,747,156 |
| 2 | Jim Simons | 0.0% | $1,772,341 | 134,472 | NEW BUY | +134,472 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | NEW BUY | +134,472 | New |
| Ken Griffin | ADD | +1,747,156 | +318.7% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | REDUCE | -1,171,407 | -68.1% |
Who Owns MLTX? Superinvestor Holdings
MOONLAKE IMMUNOTHERAPEUTICS is held by 2 tracked superinvestors, with a combined position value of $32 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.